These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Endothelium-derived nitric oxide in the control of tissue perfusion and oxygen supply: physiological and pathophysiological implications. Pohl U; Wagner K; de Wit C Eur Heart J; 1993 Nov; 14 Suppl I():93-8. PubMed ID: 8293786 [TBL] [Abstract][Full Text] [Related]
25. Adrenomedullin-induced dilation of human placental arteries is modulated by an endothelium-derived constricting factor. Jerat S; DiMarzo L; Morrish DW; Kaufman S Regul Pept; 2008 Feb; 146(1-3):183-8. PubMed ID: 17936374 [TBL] [Abstract][Full Text] [Related]
26. [Modulation of coronary tone: the role of the endothelium]. Bassenge E G Ital Cardiol; 1990 Nov; 20(11):1062-9. PubMed ID: 2090551 [No Abstract] [Full Text] [Related]
27. Endothelium-derived vasoactive factors and the control of the circulation. Vane JR; Botting RM Semin Perinatol; 1991 Feb; 15(1):4-10. PubMed ID: 2063229 [No Abstract] [Full Text] [Related]
29. [Current view of the endothelial cell]. Espinós Pérez D An R Acad Nac Med (Madr); 1991; 108(2):289-308. PubMed ID: 1767887 [No Abstract] [Full Text] [Related]
30. [Nitric oxide, vasodilatation and cirrhosis: a double (dys)equilibrium]. Sogni P; Moreau R; Lebrec D Gastroenterol Clin Biol; 1999 Jan; 23(1):101-4. PubMed ID: 10219610 [No Abstract] [Full Text] [Related]
31. Nitric oxide and the control of human vascular tone in health and disease. Calver A; Collier J; Vallance P Eur J Med; 1993 Jan; 2(1):48-53. PubMed ID: 8258006 [No Abstract] [Full Text] [Related]
33. Interaction of nitric oxide with myogenic and adrenergic vasoconstrictor processes in the control of microcirculatory blood flow. Pohl U; de Wit C Pflugers Arch; 1996; 432(3 Suppl):R107-10. PubMed ID: 8994551 [TBL] [Abstract][Full Text] [Related]
34. Circulatory responses to endothelin-1 and nitric oxide with special reference to endotoxin shock and nitric oxide inhalation. Weitzberg E Acta Physiol Scand Suppl; 1993; 611():1-72. PubMed ID: 8379340 [TBL] [Abstract][Full Text] [Related]
35. Mediators from the endothelial cell. Vane JR; Botting R Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():627-36. PubMed ID: 1825390 [No Abstract] [Full Text] [Related]
36. [Vascular endothelium. An important vasomodulator and modulator cybernetic system whose dysfunction participates in the hypertensive process]. Francischetti EA; Fagundes VG; França MF Arq Bras Cardiol; 1995 Jan; 64(1):53-68. PubMed ID: 7669013 [No Abstract] [Full Text] [Related]
37. Local regulation of the coronary circulation in health and disease: role of nitric oxide and endothelin. Lüscher TF; Wenzel RR; Noll G Eur Heart J; 1995 May; 16 Suppl C():51-8. PubMed ID: 7556273 [TBL] [Abstract][Full Text] [Related]
38. Diabetes-induced decreased sensitivity to blocking drugs of autonomic ganglia and motor endplates: new hypothesis for an old observation. Koltai M Acta Physiol Hung; 1991; 77(3-4):217-23. PubMed ID: 1755326 [No Abstract] [Full Text] [Related]
39. Role of vascular endothelial abnormalities in clinical medicine: atherosclerosis, hypertension, diabetes, and endotoxemia. Briner VA; Lüscher TF Adv Intern Med; 1994; 39():1-22. PubMed ID: 8140952 [No Abstract] [Full Text] [Related]